MX2020011765A - Composiciones herbales sinergisticas para aumentar la testosterona. - Google Patents

Composiciones herbales sinergisticas para aumentar la testosterona.

Info

Publication number
MX2020011765A
MX2020011765A MX2020011765A MX2020011765A MX2020011765A MX 2020011765 A MX2020011765 A MX 2020011765A MX 2020011765 A MX2020011765 A MX 2020011765A MX 2020011765 A MX2020011765 A MX 2020011765A MX 2020011765 A MX2020011765 A MX 2020011765A
Authority
MX
Mexico
Prior art keywords
decreased
levels
testosterone
phytochemicals
libido
Prior art date
Application number
MX2020011765A
Other languages
English (en)
Inventor
Ganga Raju Gokaraju
Rama Raju Gokaraju
Kiran Bhupathiraju
Trimurtulu Golakoti
Venkata Kanaka Ranga Raju Gokaraju
Venkateswarlu Somepalli
Venkata Krishna Raju Alluri
Original Assignee
Laila Nutraceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laila Nutraceuticals filed Critical Laila Nutraceuticals
Publication of MX2020011765A publication Critical patent/MX2020011765A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)

Abstract

Las composiciones herba1es sinérgicas comprenden una combinación de un primer ingrediente seleccionado del (los) extracto(s), fracción(es), compuesto(s) activo(s) y fitoquímicos o mezclas de los mismos de las partes de plantas de Punica granatum de un segundo ingrediente seleccionado del (los) extracto(s), fracción(es), compuesto(s) activo(s) y fitoquímicos o mezclas de los mismos derivados de las partes de plantas de Theobroma cacao para mejorar los niveles de testosterona. La invención proporciona adicionalmente el método para obtener al menos un beneficio para la salud relacionado con actividades anabólicas y androgénicas mejoradas en el cuerpo seleccionado entre mejorar los niveles de testosterona, niveles de energía, energía sostenida, vigor, resistencia, envejecimiento saludable, longevidad celular, masa muscular, fuerza muscular, función sexual (libido y función eréctil) y bienestar psicológico (estado de ánimo y concentración); y reducir el estrés en humanos y aliviar los síntomas asociados con los niveles bajos de la testosterona en humanos, como pérdida de la libido, pérdida de la función eréctil, obesidad abdominal, disminución de la masa y fuerza muscular, fatiga, cambios de humor, disminución de la densidad ósea, disminución de la densidad ósea, disminución de la memoria y la concentración.
MX2020011765A 2018-05-08 2019-05-08 Composiciones herbales sinergisticas para aumentar la testosterona. MX2020011765A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201841017306 2018-05-08
PCT/IN2019/050361 WO2019215755A2 (en) 2018-05-08 2019-05-08 Synergistic herbal compositions for testosterone boosting

Publications (1)

Publication Number Publication Date
MX2020011765A true MX2020011765A (es) 2021-03-25

Family

ID=68466711

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011765A MX2020011765A (es) 2018-05-08 2019-05-08 Composiciones herbales sinergisticas para aumentar la testosterona.

Country Status (10)

Country Link
US (1) US20210236572A1 (es)
EP (1) EP3790569A4 (es)
JP (1) JP7503502B2 (es)
KR (1) KR20210007993A (es)
CN (1) CN112672751A (es)
AU (1) AU2019264983A1 (es)
BR (1) BR112020022665A2 (es)
MX (1) MX2020011765A (es)
SG (1) SG11202010545SA (es)
WO (1) WO2019215755A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024095279A1 (en) * 2022-10-31 2024-05-10 Laila Nutraceuticals Synergistic herbal composition with nootropic activity for improving cognitive function and gaming performance

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727563B2 (en) * 1999-04-19 2010-06-01 Pom Wonderful, Llc Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
BRPI0708877A2 (pt) * 2006-03-13 2011-06-14 Hershey Co composiÇÕes de cacau em infusço e bebidas funcionais de cacau com as mesmas
US8017147B2 (en) * 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
BR112012002183A2 (pt) * 2009-07-24 2016-05-31 Amazentis Sa compostos, composições e métodos para proteger a saúde do cérebro em transtornos neurodegenerativos
CA2803360C (en) * 2010-06-25 2020-03-24 Horphag Research (Ip) Pre Ltd Composition for improving sexual wellness
CN101987082B (zh) * 2010-07-16 2013-04-03 钟术光 固体制剂及其制备方法
JP6371702B2 (ja) 2012-03-21 2018-08-08 株式会社明治 ポリフェノール安定化剤、該安定化剤を含有する組成物および加工製品
US20160166602A1 (en) * 2014-12-12 2016-06-16 Homeland Housewares, Llc Food Supplement Composition
CN104982846A (zh) * 2015-06-03 2015-10-21 安徽成祥面粉有限责任公司 一种抗衰老的红薯粉及其制备方法
US9987323B2 (en) * 2015-10-22 2018-06-05 Benny Antony Process to enhance the bioactivity of Ashwagandha extracts
US9662361B1 (en) * 2016-06-30 2017-05-30 Mahmoud Abu El Hija Method for treating azoospermia
US11123396B2 (en) * 2016-08-19 2021-09-21 Aurea Biolabs Private Limited Formulation for improving physical endurance in athletes
CN107412312A (zh) * 2017-07-06 2017-12-01 孙冠辰 一种治疗勃起功能障碍的男性保健组合物

Also Published As

Publication number Publication date
CN112672751A (zh) 2021-04-16
AU2019264983A1 (en) 2020-11-19
EP3790569A4 (en) 2022-02-16
SG11202010545SA (en) 2020-11-27
WO2019215755A2 (en) 2019-11-14
BR112020022665A2 (pt) 2021-02-09
US20210236572A1 (en) 2021-08-05
WO2019215755A3 (en) 2020-01-02
KR20210007993A (ko) 2021-01-20
JP2021523132A (ja) 2021-09-02
EP3790569A2 (en) 2021-03-17
JP7503502B2 (ja) 2024-06-20

Similar Documents

Publication Publication Date Title
Tambi et al. Standardised water‐soluble extract of Eurycoma longifolia, Tongkat ali, as testosterone booster for managing men with late‐onset hypogonadism?
JO2975B1 (en) Formulation to improve sexual health
MX347021B (es) Composiciones para tratar disfunción eréctil.
MX346576B (es) Metodos y composiciones adecuados para promover piel sana.
WO2007070779A3 (en) A method to treat premature ejaculation in humans
IN2012DN02624A (es)
NO20082703L (no) Farmasoytiske sammensetninger omfattende testosteron ved behandlingen av kvinnelig seksuell dysfunksjon
MY190273A (en) Dietary supplements and compositions for enhancing physical performance and energy levels
MX2020011765A (es) Composiciones herbales sinergisticas para aumentar la testosterona.
CO2020004801A2 (es) Uso de suplementos de aminoácidos para mejorar la síntesis de proteínas musculares
PH12018000207B1 (en) A pharmaceutical composition for prevention of diet induced obesity
MX2017006639A (es) Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso.
EP2083838A4 (en) EXTRACT FROM MEDICINAL PLANTS EXERCISING AN EFFECT AGAINST OBESITY
IN2012DN03187A (es)
BRPI0902481B8 (pt) composição farmacêutica compreendendo hemopressina e seu uso.
SG11202008440XA (en) Synergistic herbal compositions for the treatment of obesity and overweight
EA201301052A1 (ru) Биологически активная добавка к пище для нормализации уровня андрогенов мужчин, общего сосояния, снижения ожирения
MX2022014158A (es) Metodos que reducen los antojos de alimentos, promueven la perdida de peso y/o tratan el sobrepeso o la obesidad.
NZ735025A (en) Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males
MX2022009446A (es) Composiciones para activacion de nrf2 mejorada y sus metodos de uso.
TW200621231A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
PH12015502351A1 (en) Herbal compositions for treating pain and skin disorders
Shariati et al. Effect of pistacia vera oil on pituitary gonad axis and histological testis changes in adult male rats
Dadfar et al. Effect of hydroalcoholic extract of Nectaroscordum tripedale on testicular tissue changes in diabetic male rats
MY202513A (en) Synergistic herbal compositions for testosterone boosting